Articles On Paragon Care (ASX:PGC)

Highlights Selected Australian listed companies operate across healthcare and technology sectors. These companies form part of broader ASX 200 and ASX 300 market benchmarks. Sector positioning reflects diverse operational mo...

The S&P/ASX 200 Index (ASX: XJO) closed 0.37% lower on Wednesday afternoon. For the year-to-date the index is 0.63% higher and it's 4.53% above where it was this time last year. The index hasn't posted mind-blowing gains so far this...

Just 3 of 11 sectors made gains in December Gold and silver hit new all-time highs Analysts are predicting an interest rate hike by February Santa Rally fails to fully materialise The ASX 200 had a lacklustre performance in December, addi...

Happy new year!  As we all slowly get the wheels turning in 2026, brokers are also waking up from their holiday slumber. Many are now providing a fresh outlook for the year ahead.  One such company receiving new analysis is ASX ma...

The S&P/ASX 200 Index (ASX: XJO) has started the week in a subdued fashion. In afternoon trade, the benchmark index is down 0.35% to 8,731.3 points. Four ASX shares that are not letting that hold them back are listed below. Here's why...

The All Ordinaries Index (ASX: XAO) is up 6.9% over the past 12 months, with this ASX All Ords copper stock racing ahead of those gains. The strongly outperforming miner in question is Aeris Resources Ltd (ASX: AIS), with shares leaping hi...

The Woodside Energy Group Ltd (ASX: WDS) share price has been a disappointing performer again in 2025. Year to date, the energy giant's shares have lost approximately 7% of their value. This compares unfavourably to a gain of 7% by the benc...

Energy shares remain a popular hunting ground for ASX dividend investors. Two names that often get mentioned are Woodside Energy Group Ltd (ASX: WDS) and Whitehaven Coal Ltd (ASX: WHC). Both pay dividends, but the quality and cons...

Treasury Wine Estates Ltd (ASX: TWE) shares are marching higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) global wine company closed yesterday trading for $4.95. In early afternoon trade on Tuesday, shares are changing hands for...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a decent gain. At the time of writing, the benchmark index is up 0.6% to 8,752.5 points. Four ASX shares that have failed to follow the market higher today are...

There are so many ASX shares to choose from it can be hard to decide which ones to buy over others. To narrow things down, let's take a look at three popular shares and see if analysts think they are buys, holds, or sells. Here's what they...

It is fair to say that Boss Energy Ltd (ASX: BOE) shares have been absolutely smashed this year. In fact, despite a double-digit rebound on Friday, the uranium producer's shares are down almost 50% year to date. A good portion of this weakn...

Are you on the hunt for some big returns for your investment portfolio? If you are, then it could be worth looking at the ASX 200 shares listed below. That's because they have been tipped to rise at least 20% over the next 12 months. Here's...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) fought hard and managed to record a very small gain. The benchmark index rose slightly to 8,588.2 points. Will the market be able to build on this on Friday and end the week on a high? Her...

ASX inches back to neutral, up just 3 points or 0.04% Tech reverses intraday lows of -2.7% to also finish flat Blue chip stocks lead gains Blue chips prop up ASX Tech stocks nosedived in a fair approximation of the US Nasdaq’s performance...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down 0.15% to 8,572.6 points. Four ASX shares that are falling more than most today are listed...

A major healthcare industry distributor has been caught off guard by the surprise appointments of administrators and receivers to 54 pharmacies under the Infinity Pharmacy Group, most of which operate under the Priceline brand and reportedl...

ASX healthcare sector gains 1.99% in November while benchmark ASX 200 down 2.66% Mach7 rises 50% in November with health imaging stock outlining a growth strategy at its AGM  Island Pharmaceuticals rises after FDA confirms Galidesivir will...

ASX healthcare sector fell 4.83% in October and is down more than 19% YTD CSL shares fall more than 15% on October 28 after management trims FY26 guidance Nyrada surges 165% in October on board changes and progress in phase 2a trial    Wi...

The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on sector CSL had its biggest ever one day fall on August 19, down 17% following softer FY25 results and restructure plans Despite the broader...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena's Monitor keeps track of corporate earnings result releases, including broke...

The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum  Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of Febri...

The ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6.64% Morgans healthcare analyst Iain Wilkie said June likely saw some tax loss selling before EOFY  Amplia up 300% in June after complete re...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin ASX futures are set to rise at the open after US markets ended flat (S&P500) to...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US equities markets fell on rising bond yields, including a weak US 20-year bond auc...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets eased overnight after a six-day winning streak as investors rotated into...

Highlights: ASX 200 lifted following RBA’s cash rate cut, led by real estate and tech stocks Financials and consumer discretionary sectors recorded upward momentum Resources and energy shares, especially gold, trailed amid g...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

I like finding ASX small-cap stocks with an exciting future that the market could be undervaluing. In this article, I'll discuss the ASX healthcare share Paragon Care Ltd (ASX: PGC). Paragon describes itself as a leading provider of medi...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today’s Reports: ((ACF)) – Acrow...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

The ASX small-cap share space could be a great place to find under-researched but highly potential businesses. The fewer professional analysts looking at a stock, the higher the chance of that business slipping under the market's radar a...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Traders and investors have been reminded about Trump’s social media posts as a sourc...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Donald Trump’s pick of hedge fund manager Scott Bessent for Treasury secretary and a...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin The FNArena database tabulates the views of eight major Australian and international...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are indicating a positive start to the new week for the local bourse. On...

The Vanguard Australian Shares Index ETF (ASX: VAS) is trading for $104.59 per unit, up 1.15% at the time of writing on Friday. This popular ASX exchange-traded fund (ETF) seeks to track the S&P/ASX 300 Index (ASX: XKO) before fees....

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Highlights Amotiv positioned as a resilient player in the automotive sector Temple & Webster shows strong growth in the homewares segment Paragon Care gaining market share in healthcare services Amotiv, formerly known as GUD...

Control Bionics says it has overcome the “challenges” of the 2023-24 year Ord Minnett identifies the health sector stunners Noxopharm finds a drug manufacturer to kick-start its lupus trial   Health Check is renowned biotech journo Tim Bo...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((4DX)) - 4DMed...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin New research on the Pharmaceutical Wholesaling sector identifies three stocks with l...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...